Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence. 

Biotechnology

CIRCULOGENE

Mike Mullen

Patrick Shea

Christy Lee

Paul R. Walker

Scott Grissett

Eric Thompson

J. Kevin Day

Lou Apicella

Travis Wold

Jonice Vanterpool Johnson

Anthony L. Schmidt

Chen-Hsiung Yeh

The Leadership Team at CIRCULOGENE is responsible for setting the strategic direction of the company, overseeing operational execution, and ensuring alignment across all departments to drive innovation in liquid biopsy technologies. They collaborate on business development, regulatory compliance, and market strategies to position CIRCULOGENE as a leader in genomic analysis, ultimately enhancing patient care through advanced diagnostic solutions.

Leadership Team

Commercial and Business Development Team

Laboratory Operations Team

Leadership Team

About

Team members

Other teams at CIRCULOGENE

Commercial and Business Development Team

Laboratory Operations Team